The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study

References

• Argento, E., R. Capler, G. Thomas, P. Lucas, and K. W. Tupper. 2019. Exploring ayahuasca-assisted therapy for addiction: A qualitative analysis of preliminary findings among an indigenous community in Canada. Drug and Alcohol Review 38:781–89. doi:10.1111/dar.12985.
   PubMed Web of Science ®Google Scholar
• Arrieta, O., L. P. Angulo, C. Nunez-Valencia, Y. Dorantes-Gallareta, E. O. Macedo, D. Martinez-Lopez, S. Alvarado, J. F. Corona-Cruz, and L. F. Onate-Ocana. 2013. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer. Annals of Surgical Oncology 20 (6):1941–48. doi:10.1245/s10434-012-2793-5.
   PubMed Web of Science ®Google Scholar
• Barbosa, P. C. R., L. F. Tófoli, M. P. Bogenschutz, R. Hoy, L. F. Berro, E. A. V. Marinho, K. N. Areco, and M. J. Winkelman. 2018. Assessment of alcohol and tobacco use disorders among religious users of ayahuasca. Frontiers In Psychiatry / Frontiers Research Foundation 9:136. doi:10.3389/fpsyt.2018.00136.
   PubMed Web of Science ®Google Scholar
• Barker, S. A. 2018. N, N-dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function. Frontiers in Neuroscience 12:536. doi:10.3389/fnins.2018.00536.
   PubMed Web of Science ®Google Scholar
• Bastos, F. I. P. M., M. T. L. Vasconcellos, R. B. De Boni, N. B. Reis, and C. F. S. Coutinho. 2017. III Levantamento Nacional sobre o uso de drogas pela população brasileira [III National survey on drug use by the Brazilian population]. Instituto de Comunicação e Informação Científica e Tecnologia em Saúde. Rio de Janeiro: Fundação Oswaldo Cruz. Accessed https://www.arca.fiocruz.br/handle/icict/34614. January 21, 2020.
   Google Scholar
• Beaussant, Y., J. Sanders, Z. Sager, J. A. Tulsky, I. M. Braun, C. D. Blinderman, A. P. Bossis, and I. Byock. 2020. Defining the roles and research priorities for psychedelic-assisted therapies in patients with serious illness: Expert clinicians’ and investigators’ perspectives. Journal of Palliative Medicine 23 (10):1323–34. doi: 10.1089/jpm.2019.0603.
   PubMed Web of Science ®Google Scholar
• Benedetti, F. 2009. Placebo effects: Understanding the mechanisms in health and disease. New York: Oxford University Press.
   Google Scholar
• Berlowitz, I., H. Walt, C. Ghasarian, F. Mendive, and C. Martin-Soelch. 2019. Short-term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine. Journal of Psychoactive Drugs 51 (4):323–34. doi:10.1080/02791072.2019.1607956.
   PubMed Web of Science ®Google Scholar
• Braun, V., and V. Clarke. 2006. Using thematic analysis in psychology. Qualitative Research in Psychology 3 (2):77–101. doi:10.1191/1478088706qp063oa.
   Google Scholar
• Brody, H. 2000. The placebo response: Recent research and implications for family medicine. The Journal of Family Practice 49:649–54.
   PubMed Web of Science ®Google Scholar
• Brody, H. 2018. Meaning and an overview of the placebo effect. Perspectives in Biology and Medicine 61 (3):353–60. doi:10.1353/pbm.2018.0048.
   PubMed Web of Science ®Google Scholar
• Brody, H., and D. Brody. 2000. The placebo response: How you can release the body’sinner pharmacy for better health. New York: HarperCollins.
   Google Scholar
• Cruz, J. I., and S. A. Nappo. 2018. Is ayahuasca an option for the treatment of crack cocaine dependence? Journal of Psychoactive Drugs 50 (3):247–55. doi: 10.1080/02791072.2018.1447174.
   PubMed Web of Science ®Google Scholar
• Dos Santos, R. G., F. L. Osorio, J. A. Crippa, and J. E. Hallak. 2016. Antidepressive and anxiolytic effects of ayahuasca: A systematic literature review of animal and human studies. Brazilian Journal of Psychiatry 38 (1):65–72. doi:10.1590/1516-4446-2015-1701.
   PubMed Web of Science ®Google Scholar
• Dyck, E. 2019. Psychedelics and dying care: A historical look at the relationship between psychedelics and palliative care. Journal of Psychoactive Drugs 51 (2):102–07. doi:10.1080/02791072.2019.1581308.
   PubMed Web of Science ®Google Scholar
• Estrella-Parra, E. A., J. C. Almanza-Perez, and F. J. Alarcon-Aguilar. 2019. Ayahuasca: Uses, phytochemical and biological activities. Natural Products and Bioprospecting 9 (4):251–65. doi:10.1007/s13659-019-0210-5.
   PubMed Web of Science ®Google Scholar
• Fontanella, B. J., J. Ricas, E. R., and Turato. 2008. Amostragem por saturação em pesquisas qualitativas em saúde: Contribuições teóricas [Saturation sampling in qualitative health research: Theoretical contributions]. Cadernos De Saude Publica 24 (1):17–27. doi:10.1590/S0102-311X2008000100003.
   PubMed Web of Science ®Google Scholar
• Fotiou, E., and A. K. Gearin. 2019. Purging and the body in the therapeutic use of ayahuasca. Social Science & Medicine 239:112532. doi:10.1016/j.socscimed.2019.112532.
   PubMed Web of Science ®Google Scholar
• Franquesa, A., A. Sainz-Cort, S. Gandy, J. Soler, M. A. Alcazar-Corcoles, and J. C. Bouso. 2018. Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach. Psychiatry Research 264:334–39. doi:10.1016/j.psychres.2018.04.012.
   PubMed Web of Science ®Google Scholar
• Galvão, A. C. M., R. N. de Almeida, E. A. D. S. Silva, F. A. M. Freire, F. Palhano-Fontes, H. Onias, E. Arcoverde, J. P. Maia-de-Oliveira, D. B. de Araújo, B. Lobão-Soares, et al. 2018. Cortisol modulation by ayahuasca in patients with treatment resistant depression and healthy controls. Frontiers In Psychiatry / Frontiers Research Foundation 9:185.
   PubMed Web of Science ®Google Scholar
• Galvão-Coelho, N. L., A. C. M. Galvão, R. N. de Almeida, F. Palhano-Fontes, I. Campos Braga, B. Lobão Soares, J. P. Maia-de-Oliveira, D. Perkins, J. Sarris, and D. B. de Araujo. 2020. Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca. Journal of Psychopharmacology (Oxford, England) 34 (Advance online publication):1125–33. doi:10.1177/0269881120936486.
   PubMed Web of Science ®Google Scholar
• Gasser, P., K. Kirchner, T. Passie. 2015. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology (Oxford, England) 29 (1):57–68. doi:10.1177/0269881114555249
   PubMed Web of Science ®Google Scholar
• Glaser, B. G., and A. L. Strauss. 1999. The discovery of grounded theory: Strategies for qualitative research. New Brunswick: Aldine Transaction.
   Google Scholar
• Grassi, L., R. Caruso, K. Hammelef, M. G. Nanni, and M. Riba. 2014. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: A review. International Review of Psychiatry 26 (1):44–62. doi:10.3109/09540261.2013.842542.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., M. W. Johnson, M. A. Carducci, A. Umbricht, W. A. Richards, B. D. Richards, M. P. Cosimano, and M. A. Klinedinst. 2016. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England) 30 (12):1181–97. doi:10.1177/0269881116675513.
   PubMed Web of Science ®Google Scholar
• Hamill, J., J. Hallak, S. M. Dursun, and G. Baker. 2019. Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology 17 (2):108–28.
   PubMed Web of Science ®Google Scholar
• Harris, R., and L. Gurel. 2012. A study of ayahuasca use in North America. Journal of Psychoactive Drugs 44 (3):209–15. doi:10.1080/02791072.2012.703100.
   PubMed Web of Science ®Google Scholar
• Horák, M., L. Hasíková, and N. Verter. 2018. Therapeutic potential ascribed to ayahuasca by users in the Czech republic. Journal of Psychoactive Drugs 50 (5):430–36. doi:10.1080/02791072.2018.1511878.
   PubMed Web of Science ®Google Scholar
• Iovieno, N., E. Tedeschini, V. E. Ameral, M. Rigatelli, and G. I. Papakostas. 2011. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: A meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. International Clinical Psychopharmacology 26 (2):69–74. doi:10.1097/YIC.0b013e328340775e.
   PubMed Web of Science ®Google Scholar
• Koenig, H. G. 2002. Spirituality in patient care: Why, how, when, and what. West Conshohocken: Templeton Foundation Press.
   Google Scholar
• Labate, B. C. 2004. A reinvenção do uso da ayahuasca nos centros urbanos [The reinvention of the use of ayahuasca in urban centers]. Campinas: Mercado das Letras; São Paulo: Fapesp.
   Google Scholar
• Labate, B. C., and K. Feeney. 2012. Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. The International Journal on Drug Policy 23 (2):154–61. doi:10.1016/j.drugpo.2011.06.006.
   PubMed Web of Science ®Google Scholar
• Labate, B. C., and W. S. Araújo. 2002. O uso ritual da ayahuasca. [The ritual use of ayahuasca]. Campinas: Mercado das Letras; São Paulo: Fapesp.
   Google Scholar
• Loizaga-Velder, A., and A. L. Pazzi. 2014. Therapist and patient perspectives on ayahuasca-assisted treatment for substance dependence. In The therapeutic use of ayahuasca, ed. B. C. Labate and C. Cavnar, 133–152. Heidelberg, Baden-Württemberg: Springer.
   Google Scholar
• Luna, L. E. 2011. Indigenous and mestizo use of ayahuasca. An overview. In The Ethnopharmacology of ayahuasca, ed. R. G. D. Santos, 1–21. Kerala: Transworld Research Network.
   Google Scholar
• Malone, T. C., S. E. Mennenga, J. Guss, S. K. Podrebarac, L. T. Owens, A. P. Bossis, A. B. Belser, G. Agin-Liebes, M. P. Bogenschutz, and S. Ross. 2018. Individual experiences in four cancer patients following psilocybin-assisted psychotherapy. Frontiers in Pharmacology 9:256. doi:10.3389/fphar.2018.00256.
   PubMed Web of Science ®Google Scholar
• Maté, G. 2014. Postscript—Psychedelics in unlocking the unconscious: From cancer to addiction. In The therapeutic use of ayahuasca, ed. B. C. Labate and C. Cavnar, 217–24. Berlin, Heidelberg: Springer-Verlag.
   Google Scholar
• Mitchell, A. J., M. Chan, H. Bhatti, M. Halton, L. Grassi, C. Johansen, and N. Meader. 2011. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology 12 (2):160–74. doi:10.1016/S1470-2045(11)70002-X.
   PubMed Web of Science ®Google Scholar
• Moreton, S. G., L. Szalla, R. E. Menzies, and A. F. Arena. 2020. Embedding existential psychology within psychedelic science: Reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology (Berl) 237 (1):21–32. doi:10.1007/s00213-019-05391-0.
   PubMed Web of Science ®Google Scholar
• Ona, G. M., K. T. Massaguer, A. Gomariz, D. F. Jiménez, R. G. Dos Santos, J. E. C. Hallak, M. A. Alcázar-Córcoles, and J. C. Bouso. 2019. Ayahuasca and public health: Health status, psychosocial well-being, lifestyle, and coping strategies in a large sample of ritual ayahuasca users. Journal of Psychoactive Drugs 51 (2):135–45. doi:10.1080/02791072.2019.1567961.
   PubMed Web of Science ®Google Scholar
• Ostuzzi, G., F. Matcham, S. Dauchy, C. Barbui, and M. Hotopf. 2018. Antidepressants for the treatment of depression in people with cancer. Cochrane Database of Systematic Reviews 4:CD011006.
   PubMed Web of Science ®Google Scholar
• Palhano-Fontes, F., D. Barreto, H. Onias, K. C. Andrade, M. M. Novaes, J. A. Pessoa, S. A. Mota-Rolim, F. L. Osorio, R. Sanches, R. G. Dos Santos, et al. 2019. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychological Medicine 49 (4):655–63. doi:10.1017/S0033291718001356.
   PubMed Web of Science ®Google Scholar
• Passie, T. 2012. Healing with entactogens – Therapist and patient perspectives on MDMA-assisted group psychotherapy. Santa Cruz, CA: MAPS.
   Google Scholar
• Patton, M. Q. 2015. Qualitative research; and evaluation methods: Integrating theory and practice. 4th ed. Thousand Oaks: Sage/Learning Matters.
   Google Scholar
• Puchalski, C. M. 2012. Spirituality in the cancer trajectory. Annals of Oncology 23 (suppl_3):49–55. doi:10.1093/annonc/mds088.
   PubMed Web of Science ®Google Scholar
• Reiche, S., L. Hermle, S. Gutwinski, H. Jungaberle, P. Gasser, and T. Majić. 2018. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review. Progress in Neuro-psychopharmacology & Biological Psychiatry 81:1–10. doi:10.1016/j.pnpbp.2017.09.012.
   PubMed Web of Science ®Google Scholar
• Renelli, M., J. Fletcher, K. W. Tupper, N. Files, A. Loizaga-Velder, and A. Lafrance. 2018. An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders. Eating and Weight Disorders 25 (2):437–44. doi: 10.1007/s40519-018-0619-6..
   PubMed Web of Science ®Google Scholar
• Riba, J., M. Valle, G. Urbano, M. Yritia, A. Morte, and M. J. Barbanoj. 2003. Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. The Journal of Pharmacology and Experimental Therapeutics 306 (1):73–83. doi:10.1124/jpet.103.049882.
   PubMed Web of Science ®Google Scholar
• Ross, S., A. Bossis, J. Guss, G. Agin-Liebes, T. Malone, B. Cohen, S. E. Mennenga, A. Belser, K. Kalliontzi, J. Babb, et al. 2016. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology (Oxford, England) 30 (12):1165–80. doi:10.1177/0269881116675512.
   PubMed Web of Science ®Google Scholar
• Schenberg, E. E. 2013. Ayahuasca and cancer treatment. SAGE Open Medicine 1:2050312113508389. doi:10.1177/2050312113508389.
   Google Scholar
• Schenberg, E. E., J. F. Alexandre, R. Filev, A. M. Cravo, J. R. Sato, S. D. Muthukumaraswamy, M. Yonamine, M. Waguespack, I. Lomnicka, S. A. Barker, et al. 2015. Acute biphasic effects of ayahuasca. PLoS One 10 (9):e0137202. doi:10.1371/journal.pone.0137202.
   PubMed Web of Science ®Google Scholar
• Schmid, J. T., H. Jungaberle, and R. Verres. 2010. Subjective theories about (self‐)treatment with ayahuasca. Anthropology of Consciousness 21 (2):188–204. doi:10.1111/j.1556-3537.2010.01028.x.
   Google Scholar
• Shanon, B. 2002. The antipodes of the mind: Charting the phenomenology of the ayahuasca experience. Oxford: Oxford University Press.
   Google Scholar
• Shim, E. J., and J. H. Park. 2012. Suicidality and its associated factors in cancer patients: Results of a multi-center study in Korea. International Journal of Psychiatry in Medicine 43 (4):381–403. doi:10.2190/PM.43.4.g.
   PubMed Web of Science ®Google Scholar
• Soler, J., M. Elices, A. Franquesa, S. Barker, P. Friedlander, A. Feilding, J. C. Pascual, and J. Riba. 2016. Exploring the therapeutic potential of Ayahuasca: Acute intake increases mindfulness-related capacities. Psychopharmacology (Berl) 233 (5):823–29. doi:10.1007/s00213-015-4162-0.
   PubMed Web of Science ®Google Scholar
• Soler, J. M., E. E. Dominguez-Clave, J. C. Pascual, A. Feilding, M. Navarro-Gil, J. Garca-Campayo, and J. Riba. 2018. Four weekly ayahuasca sessions lead to increases in “acceptance” capacities: A comparison study with a standard 8-week mindfulness training program. Frontiers in Pharmacology 9:8. doi:10.3389/fphar.2018.00224.
   PubMed Web of Science ®Google Scholar
• Thomas, G., P. Lucas, N. R. Capler, K. W. Tupper, and G. Martin. 2013. Ayahuasca-assisted therapy for addiction: Results from a preliminary observational study in Canada. Current Drug Abuse Reviews 6 (1):30–42. doi:10.2174/15733998113099990003.
   PubMedGoogle Scholar
• Tong, A., P. Sainsbury, and J. Craig. 2007. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal For Quality In Health Care : Journal Of The International Society For Quality In Health Care / ISQua 19 (6):349–57. doi:10.1093/intqhc/mzm042.
   PubMed Web of Science ®Google Scholar
• Trichter, S., J. Klimo, and S. Krippner. 2009. Changes in spirituality among ayahuasca ceremony novice participants. Journal of Psychoactive Drugs 41 (2):121–34. doi:10.1080/02791072.2009.10399905.
   PubMed Web of Science ®Google Scholar
• Uthaug, M. V., K. van Oorsouw, K. P. C. Kuypers, M. van Boxtel, N. J. Broers, N. L. Mason, S. W. Toennes, J. Riba, and J. G. Ramaekers. 2018. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Psychopharmacology (Berl) 235 (10):2979–89. doi:10.1007/s00213-018-4988-3.
   PubMed Web of Science ®Google Scholar
• Weiss, S. 2018. People are drinking ayahuasca to treat physical illnesses. Last Modified May 22, 2018. Acessed January 21, 2020. https://www.vice.com/en_us/article/neknyx/drinking-ayahuasca-to-treat-pain-illness.
   Google Scholar
• Wolff, T. J., S. Ruffell, N. Netzband, and T. Passie. 2019. A phenomenology of subjectively relevant experiences induced by ayahuasca in Upper Amazon vegetalismo tourism. Journal of Psychedelic Studies 3:295–307. doi:10.1556/2054.2019.007.
   Google Scholar